Repligen to Report Second Quarter 2022 Financial Results
Webcast and Conference Call to Be Held Tuesday, August 2, 2022 at 8:30 a.m. EDTWALTHAM, Mass., July 19, 2022 (GLOBE...
News
Quipt Home Medical to Participate at the 42nd Annual Canaccord Growth Conference on August 8th – 11th
Webcasted Presentation to be Held Thursday August 11thCINCINNATI, July 19, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt”)...
CorVel Announces Quarterly Earnings Release Webcast
FORT WORTH, Texas, July 19, 2022 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Michael Combs, President and Chief Executive Officer Brandon O’Brien,...
Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy (GA)
PDUFA target action date is November 26, 2022FDA has stated that it is not currently planning to hold an advisory...
NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression
Indication demonstrates NeuroStar TMS safety and efficacy in improving anxiety symptoms in depressed patientsMALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE)...
Clene Receives Positive EMA Opinion on Orphan Drug Designation for CNM-Au8® for the Treatment of ALS
SALT LAKE CITY, July 19, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its...
Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension
- Validates the safety profile and clinical efficacy of LUMRYZ - Pursuing strategies to accelerate final approval DUBLIN, Ireland, July...
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer
BOSTON, July 19, 2022 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biopharmaceutical company aiming to transform the lives...
Tilray Medical Launches Cannabis Education Platform ‘WeCare-MedicalCannabis’ Across Europe
‘WeCare-MedicalCannabis’ A Comprehensive Resource for Medical Cannabis Education is Now Available in English, German, French, and PortugueseNEUMÜNSTER, Germany, July 19,...
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs
Company aims to increase health equity by developing more accessible treatment modalities better suited for existing healthcare infrastructureDENVER, July 19,...
XORTX Announces Submission to European Medicines Agency
Scientific Advice from EMA Committee for Medicinal Products for Human Use RequestedCALGARY, Alberta, July 19, 2022 (GLOBE NEWSWIRE) -- XORTX...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2022
Company Announcement Net sales of DARZALEX® in the second quarter of 2022 totaled USD 1,986 millionGenmab receives royalties on worldwide...
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Ji’an, Jiangxi, China, July 19, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and...
Mainz Biomed Appoints Dr. Timothy Wang to Newly Formed Medical Advisory Board
Renowned Experts to Support ColoAlert’s U.S. Pivotal Clinical Trial and Development of Additional Cancer DiagnosticsDr. Wang is the GI (Gastrointestinal)...
Nexstim Receives an NBS System Order from a Finnish Customer
Press release, Helsinki, 19 July 2022 at 10 AM (EET) Nexstim Receives an NBS System Order from a Finnish Customer...
Bavarian Nordic Secures Significant European Smallpox/Monkeypox Vaccine Order for 2023
Bavarian Nordic to supply an additional 1.5 million doses of IMVANEX® vaccine to an undisclosed European countryDeliveries starting in the...
eureKARE launches synthetic biology studio network with inaugural biomedical studio in Belgium
eureKARE launches synthetic biology studio network with inaugural biomedical studio in Belgium Georges Rawadi appointed eureKARE’s Chief of Biotech Studio...
Sequana Medical completes enrollment in Phase 2a SAHARA I DSR study, reports disease-modifying profile for Short Term DSR and provides business update
PRESS RELEASEREGULATED INFORMATION – INSIDE INFORMATION19 July 2022, 07:00 am CEST DSR (Direct Sodium Removal) heart failure drug development: Completed...
Doug Kohrs appointed to Sequana Medical Board of Directors
Highly experienced US medtech leader brings more than 40 years’ experience Ghent, Belgium – 19 July 2022 – Sequana Medical...
Novartis delivers continued strong momentum of key growth brands, progress on strategic initiatives and confirms FY’22 Group guidance
Ad hoc announcement pursuant to Art. 53 LR Q2 sales grew +5% cc1 (-1% USD) Innovative Medicines (IM) sales grew...